Anxiety - Depression
This is a clinical outcome trial to determine if urinary neurotransmitter measurements are useful in identifying and treating people with mild to moderate anxiety and depression.
Entry Criteria
- Adults or adolescents with mild to moderate anxiety and depression
- Untreated or undergo a 1 month wash out period of anxiety/depression medications
Protocol
Baseline and 30 day Interval Measurements:
- Symptoms
- urinary neurotransmitters
- electrodermal screening
Treatment
Specific neurotransmitter amino acid therapy based on measurements
Benefits
Reduced office visits and laboratory fees